ARCHIVES

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

This article is from The Cancer Letter archive.

Vol. 31 No. 43 | November 23, 2005

Download PDF Visit The Full Archive

Related Articles

Greenberg: More Work Needs to be Done

November 7, 2014

DCT Board Approves Management Support, Drug Storage Concepts

March 3, 1989

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

Tobacco Control: Cigarette Consumption In ASSIST States 10% Below Other States

January 17, 1997

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997